ATE382036T1 - (1-indanon)-(1,2,3,6-tetrahydropyridin)derivat - Google Patents
(1-indanon)-(1,2,3,6-tetrahydropyridin)derivatInfo
- Publication number
- ATE382036T1 ATE382036T1 AT03712926T AT03712926T ATE382036T1 AT E382036 T1 ATE382036 T1 AT E382036T1 AT 03712926 T AT03712926 T AT 03712926T AT 03712926 T AT03712926 T AT 03712926T AT E382036 T1 ATE382036 T1 AT E382036T1
- Authority
- AT
- Austria
- Prior art keywords
- alk
- optionally substituted
- cyc
- halo
- oalk
- Prior art date
Links
- DTFCWQJCSNIAGW-UHFFFAOYSA-N 2,3-dihydroinden-1-one;1,2,3,6-tetrahydropyridine Chemical class C1CC=CCN1.C1=CC=C2C(=O)CCC2=C1 DTFCWQJCSNIAGW-UHFFFAOYSA-N 0.000 title 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 4
- -1 (1-Indanone)-tetrahydropyridine derivatives Chemical class 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003368 amide group Chemical group 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 230000002460 anti-migrenic effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000001966 cerebroprotective effect Effects 0.000 abstract 1
- 239000000544 cholinesterase inhibitor Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229960003135 donepezil hydrochloride Drugs 0.000 abstract 1
- XWAIAVWHZJNZQQ-UHFFFAOYSA-N donepezil hydrochloride Chemical compound [H+].[Cl-].O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 XWAIAVWHZJNZQQ-UHFFFAOYSA-N 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 108010085082 sigma receptors Proteins 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002095352 | 2002-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382036T1 true ATE382036T1 (de) | 2008-01-15 |
Family
ID=28671806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03712926T ATE382036T1 (de) | 2002-03-29 | 2003-03-25 | (1-indanon)-(1,2,3,6-tetrahydropyridin)derivat |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7378425B2 (de) |
| EP (1) | EP1491531B1 (de) |
| JP (1) | JP4405811B2 (de) |
| AT (1) | ATE382036T1 (de) |
| AU (1) | AU2003221117A1 (de) |
| DE (1) | DE60318306T2 (de) |
| ES (1) | ES2297141T3 (de) |
| WO (1) | WO2003082820A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005154320A (ja) * | 2003-11-25 | 2005-06-16 | Ss Pharmaceut Co Ltd | 眼疾患治療薬 |
| WO2005076749A2 (en) * | 2004-02-11 | 2005-08-25 | Jubilant Organosys Limited | A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine |
| US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| JP5930573B2 (ja) | 2007-03-01 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤の新規使用 |
| EP2142514B1 (de) | 2007-04-18 | 2014-12-24 | Probiodrug AG | Thioharnstoffderivate als glutaminylcyclaseinhibitoren |
| JP5934645B2 (ja) | 2009-09-11 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体 |
| AU2011215870B2 (en) * | 2010-02-09 | 2016-01-28 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| NZ602312A (en) | 2010-03-10 | 2014-02-28 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
| EP2686313B1 (de) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazolderivate als glutaminylcyclase-hemmer |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| PL2931276T3 (pl) | 2012-12-13 | 2018-06-29 | H. Lundbeck A/S | Kompozycje zawierające wortioksetynę i donepezil |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| JP6433482B2 (ja) | 2013-03-15 | 2018-12-05 | エージンバイオ， インコーポレイテッド | 認知機能を改善するための方法および組成物 |
| WO2016191288A1 (en) | 2015-05-22 | 2016-12-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
| RU2019104378A (ru) | 2016-07-19 | 2020-08-19 | Байер Кропсайенс Акциенгезельшафт | Конденсированные бициклические гетероциклические производные в качестве средств для борьбы с вредителями |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000319257A (ja) | 1969-01-06 | 2000-11-21 | Eisai Co Ltd | １−ベンジル−４−［（５，６−ジメトキシ−２−フルオロ−１−インダノン）−２−イル］メチルピペリジン |
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| US5109002A (en) | 1989-09-08 | 1992-04-28 | Du Pont Merck Pharmaceutical Company | Antipsychotic 1-cycloalkylpiperidines |
| JP3421702B2 (ja) | 1993-03-26 | 2003-06-30 | 大正製薬株式会社 | シグマ受容体拮抗薬 |
| JP2883970B2 (ja) | 1993-07-28 | 1999-04-19 | 参天製薬株式会社 | 新規１，４−（ジフェニルアルキル）ピペラジン誘導体 |
| US5849760A (en) | 1993-12-09 | 1998-12-15 | Institut De Recherche Jouveinal | 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors |
| US5994369A (en) | 1995-04-05 | 1999-11-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders |
| JPH1134981A (ja) | 1997-07-17 | 1999-02-09 | Nakashima Propeller Kk | 二重プロペラ装置 |
| JP4242032B2 (ja) * | 1999-03-03 | 2009-03-18 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ４−置換ピペリジン誘導体フッ化物 |
| JP4242048B2 (ja) * | 1999-09-01 | 2009-03-18 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ４−置換ピペリジン誘導体 |
-
2003
- 2003-03-25 EP EP03712926A patent/EP1491531B1/de not_active Expired - Lifetime
- 2003-03-25 AT AT03712926T patent/ATE382036T1/de not_active IP Right Cessation
- 2003-03-25 JP JP2003580288A patent/JP4405811B2/ja not_active Expired - Fee Related
- 2003-03-25 ES ES03712926T patent/ES2297141T3/es not_active Expired - Lifetime
- 2003-03-25 AU AU2003221117A patent/AU2003221117A1/en not_active Abandoned
- 2003-03-25 DE DE60318306T patent/DE60318306T2/de not_active Expired - Lifetime
- 2003-03-25 WO PCT/JP2003/003630 patent/WO2003082820A1/ja not_active Ceased
-
2004
- 2004-09-15 US US10/940,747 patent/US7378425B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2003082820A1 (ja) | 2005-08-04 |
| ES2297141T3 (es) | 2008-05-01 |
| US7378425B2 (en) | 2008-05-27 |
| EP1491531A1 (de) | 2004-12-29 |
| DE60318306T2 (de) | 2008-12-11 |
| US20050124642A1 (en) | 2005-06-09 |
| DE60318306D1 (de) | 2008-02-07 |
| EP1491531A4 (de) | 2006-04-05 |
| WO2003082820A1 (en) | 2003-10-09 |
| JP4405811B2 (ja) | 2010-01-27 |
| EP1491531B1 (de) | 2007-12-26 |
| AU2003221117A1 (en) | 2003-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60318306D1 (de) | (1-indanon)-(1,2,3,6-tetrahydropyridin)derivat | |
| PT1238979E (pt) | Compostos heterociclicos fundidos processo de preparacao dos compostos e farmacos que os contem | |
| PL331536A1 (en) | Muscarinic antagonists with an etheric bond | |
| AU4971796A (en) | Benzylpiperidines and piperazines as muscarinic antagonists | |
| ECSP055684A (es) | Antagonistas del receptor opiode | |
| NO960888L (no) | Bicykliske aromatiske forbindelser som terapeutiske midler | |
| ES2135543T3 (es) | Piperidinas (4-aril-sustituidas) como antagonistas de los receptores de neuroquininas. | |
| SI1682503T1 (sl) | Derivati N-(fenil(alkilpiperidin-2-il)metil)benzamida, njihova priprava in njihova terapevtska uporaba | |
| PL1706113T3 (pl) | Sposób wytwarzania chlorowodorku 4-(2-dipropyloaminoetylo)-1,3-dihydro-2H-indol-2-onu | |
| MX9703025A (es) | Proceso para preparar levobupivacaina y sus analogos. | |
| NO20025641D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| CO5200757A1 (es) | Derivados de 4-indol benzamidas con actividad contra la osteoporosis, sus sales farmaceuticamente aceptables y composiciones farmaceuticas que los contienen | |
| EP1553084A4 (de) | Piperidinderivat, verfahren zu dessen herstellung und verwendung | |
| AU2003257493A1 (en) | Pleuromutilin derivatives as antimicrobbials | |
| PE20071177A1 (es) | Derivados de 3,5-piridina como inhibidores de renina | |
| DK0398578T3 (da) | 2-piperidino-1-alkanolderivater som antiiskæmiske midler | |
| ATE335734T1 (de) | Verbindungen und methoden zur behandlung von proliferativen krankheiten, retinopathie und arthritis | |
| MX9701955A (es) | Antagonistas de neuroquinina. | |
| BG100883A (en) | Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors | |
| EP1238970A4 (de) | Zyklische aminverbindungen als ccr5-rezeptor antagonisten | |
| CY1110613T1 (el) | Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων | |
| DK1034174T3 (da) | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer | |
| WO2001064659A3 (en) | Indane derivatives and their use as cell adhesion inhibitors | |
| TW200612965A (en) | Methods for preparing p2x7 inhibitors | |
| YU10402A (sh) | Supstituisani 3-fenil-5-alkoksi-1,3,4-oksidiazol-2-oni i njihova upotreba za proizvodnju leka |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |